A Phase I, clinical trial to assess the safety and immunogenicity of P. Falciparum vaccines Posted on May 14, 2019May 14, 2019 by Suzanne Kerbavcic The project has awarded to V. S. Chauhan at ICGEB New Delhi.Duration: 2018-2020Donor/funding programme:Partners:Syngene International LtdShare this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X Share on LinkedIn (Opens in new window) LinkedIn